## VRT: Vertiv Holdings Co - XLI: Industrials

### Executive Summary

VALUE thesis: PEG 0.86 indicates fundamental undervaluation. Quality metrics strong (ROE 39%, ROA 11%). Consistent execution (4/4 quarters beat estimates). Caution: declining volume (46% of avg).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($148.10)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** BULLISH (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Goldman Sachs | $204 | $182 | +12% |
| 2025-12-09 | Wolfe Research | $0 | $0 | 0% |
| 2025-12-08 | Citigroup | $220 | $198 | +11% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Goldman Sachs | main | Buy |
| 2025-12-09 | Wolfe Research | down | Peer Perform |
| 2025-12-08 | Citigroup | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 12 ($1.05M) |
| Sells | 3 ($0.94M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 10.2% (+2.2%)
- Blackrock Inc.: 9.4% (+2.4%)
- Bank of America Corp: 2.5% (-6.2%)
- State Street Corpora: 2.2% (+2.3%)
- JPMORGAN CHASE & CO: 2.2% (+101.7%)

### Key Risks

1. High beta (2.03) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Near-term weakness: 6.1% below SMA50 despite long-term uptrend.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 0.86 indicates undervaluation relative to growth. Quality metrics strong (ROE 39%, ROA 11%). Revenue growth strong at 20% YoY. Analyst sentiment positive (2 raises, avg +12%). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $62.8B |
| Beta | 2.03 |
| 52W Range | $53.60 - $202.45 |
| Short Interest | 2.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.86 |
| Forward P/E | 31.1 |
| Current P/E | 39.8 |
| YoY Growth | 27.9% |
| EPS Direction | RISING |

### Technicals

MRS_20 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 7.5pp (needs >4.0% for momentum thesis). AM_20 at -3.4% indicates price below own 20MA trend. Underperforming sector by 4.0pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.24x) but short-term weakness (below SMA20). RSI neutral at 46. Volume at 46% of 20MA suggests lack of conviction. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.45% (CS: 12) | Weak |
| RSI_14 | 45.8 | Neutral |
| MACD Histogram | 0.02 | Bullish |
| vs SMA20 | 0.966x | Below |
| vs SMA50 | 0.939x | Below |
| vs SMA200 | 1.243x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $164.30
- **Stop Loss:** $148.10 (9.9% risk)
- **Target:** $196.70 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 81
- **Position Value:** $13,308.30
- **Portfolio %:** 13.31%
- **Risk Dollars:** $1,320.00
- **Risk Per Trade:** 1.32%
- **Modifiers:** L1 110% | L2 120% | Combined 1.32x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

**Next:** 2026-02-11 (Est: $1.29)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.99 | $1.24 | +25.0% |
| 2025Q2 | $0.83 | $0.95 | +14.4% |
| 2025Q1 | $0.62 | $0.64 | +3.9% |
| 2024Q4 | $0.82 | $0.99 | +20.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*